Can a simple assessment make chemotherapy safer for seniors?
NCT ID NCT07485634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized care plan, based on a geriatric assessment, can reduce severe side effects in older adults (65+) starting chemotherapy for common cancers. Participants are randomly assigned to receive the assessment-driven plan plus usual care, or usual care alone. The goal is to see if this approach lowers the risk of serious toxicities, hospital visits, and treatment disruptions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, Hong Kong,
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a plasma beam stop colon polyps from coming back?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Smart sensors at home could spot frailty early and lend a helping hand
- Can a simple CT scan catch lung cancer earlier in kuwait?